Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1051 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 113.36 USD | -0.96% | +0.51% | +29.33% | +2.76% | 7.77 B USD | ||
| 1054 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 128.21 USD | -0.08% | +9.57% | +34.18% | +82.82% | 7.82 B USD | ||
| 1099 |  LQDA Liquidia Corporation - Common Stock | 82.55 USD | +1.63% | +4.26% | +28.16% | +265.27% | 7.34 B USD | ||
| 1124 |  COGT Cogent Biosciences, Inc. - Common Stock | 40.61 USD | +1.50% | +3.70% | +27.34% | +159.16% | 6.94 B USD | ||
| 1131 |  SRRK Scholar Rock Holding Corporation - Common Stock | 56.78 USD | +0.39% | +4.66% | +27.74% | +89.14% | 6.80 B USD | ||
| 1175 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 321.26 USD | +0.57% | +3.15% | +32.76% | +71.69% | 6.44 B USD | ||
| 1188 |  CNTA Centessa Pharmaceuticals plc - American Depositary Shares | 40.50 USD | 0.00% | +1.07% | +1.94% | +65.17% | 6.27 B USD | ||
| 1195 |  BLTE Belite Bio Inc - American Depositary Shares | 152.68 USD | -3.18% | -0.83% | +6.48% | +154.47% | 6.01 B USD | ||
| 1207 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 65.86 USD | +3.93% | +9.33% | +26.31% | +61.46% | 6.37 B USD | ||
| 1251 |  CRSP CRISPR Therapeutics AG - Common Shares | 60.33 USD | -0.72% | +7.73% | +14.80% | +7.92% | 5.82 B USD | ||
| 1261 |  ERAS Erasca, Inc. - Common Stock | 19.10 USD | +4.03% | +4.83% | +44.48% | +1181.88% | 5.94 B USD | ||
| 1269 |  CELC Celcuity Inc. - Common Stock | 114.24 USD | -1.28% | +8.15% | +30.08% | +740.62% | 5.57 B USD | ||
| 1302 |  TVTX Travere Therapeutics, Inc. - Common Stock | 58.28 USD | +0.74% | +3.89% | +21.72% | +102.57% | 5.42 B USD | ||
| 1317 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 96.00 USD | +0.25% | +3.43% | +16.46% | +421.46% | 5.25 B USD | ||
| 1329 |  LEGN Legend Biotech Corporation - American Depositary Shares | 28.26 USD | +2.10% | -3.65% | -11.08% | -11.63% | 5.23 B USD | ||
| 1364 |  VKTX Viking Therapeutics, Inc. - Common Stock | 40.60 USD | -3.63% | +4.16% | +36.42% | +32.72% | 4.71 B USD | ||
| 1373 |  DFTX Definium Therapeutics, Inc. - Common Shares | 45.82 USD | +3.01% | -0.74% | +97.50% | +203.24% | 5.00 B USD | ||
| 1400 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 44.95 USD | +4.22% | +11.21% | +26.80% | +195.14% | 4.84 B USD | ||
| 1425 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 26.24 USD | +0.15% | +4.04% | +20.04% | +24.83% | 4.49 B USD | ||
| 1427 |  VCYT Veracyte, Inc. - Common Stock | 55.06 USD | -1.96% | -7.06% | +14.83% | +49.21% | 4.39 B USD |
Nouvelles Biotechnology Stocks
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Nurix Therapeutics : les résultats sous l’œil de l’accord avec Roche
L’action Edgewise Therapeutics atteint un sommet historique à 43,96 $
Stifel abaisse la note de Crinetics à Conserver après l’acquisition par Vertex
Gainers Biotechnology Stocks
 APLMW Apollomics Inc. - Warrant | 0.0184 | +53.33% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 PRME Prime Medicine, Inc. - Common Stock | 4.68 | +17.29% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.17 | +13.21% |
 ANVS Annovis Bio, Inc. Common Stock | 2.16 | +11.92% |
 BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.27 | +11.82% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
 ELOX Eloxx Pharmaceuticals, Inc. | 12.01 | +9.68% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0133 | -20.83% |
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.31 | -16.61% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 PHGE BiomX Inc. COmmon Stock | 0.26 | -13.33% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1053 | -11.21% |
 ICUCW SeaStar Medical Holding Corporation - Warrant | 0.0204 | -10.92% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.44 | -10.20% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.34 | -9.83% |